Reske Martina, Kellermann Thilo, Habel Ute, Jon Shah N, Backes Volker, von Wilmsdorff Martina, Stöcker Tony, Gaebel Wolfgang, Schneider Frank
Department of Psychiatry and Psychotherapy, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany.
J Psychiatr Res. 2007 Dec;41(11):918-27. doi: 10.1016/j.jpsychires.2007.02.009. Epub 2007 Apr 27.
Patients with schizophrenia are characterized by emotional symptoms such as flattened affect which are accompanied by cerebral dysfunctions. This study aimed at determining changes of mood-related neural correlates under standardized pharmacological therapy in first-episode schizophrenia.
Using fMRI in a longitudinal approach, 10 first-episode schizophrenia patients (6 males) and 10 healthy subjects (same education, gender and age) were investigated during sad and happy mood induction using facial expressions. Reassessments were carried out following 6 months of standardized antipsychotic treatment. Data analysis focussed on therapy-related changes in cerebral activation and on stable, therapy-independent group differences.
According to self ratings, mood induction was successful in both groups and did not reveal time-dependent changes. Patients revealed stable hypoactivations in core brain regions of emotional processing like the anterior cingulate cortex, orbitofrontal and temporal areas as well as the hippocampus. Therapy-related signal increases in pre- and postcentral, inferior temporal and frontal areas were restricted to sadness.
Stable dysfunctions which are unaffected by therapy and symptom improvement were found in cortico-limbic regions crucially involved in emotion processing. They presumably reflect patients' difficulties in emotion regulation and emotional memory processes. However, therapy-related activation changes were also observed and demonstrate efficacy of antipsychotic therapy on improving emotion functionality. They may represent an increased usage of autobiographic emotional memories and an improved strategy to experience an emotion by mirroring someone else's emotions.
精神分裂症患者具有情感症状,如情感平淡,并伴有脑功能障碍。本研究旨在确定首发精神分裂症患者在标准化药物治疗下与情绪相关的神经关联变化。
采用功能磁共振成像纵向研究方法,对10例首发精神分裂症患者(6例男性)和10名健康受试者(受教育程度、性别和年龄相同)在通过面部表情诱发悲伤和快乐情绪时进行研究。在标准化抗精神病药物治疗6个月后进行重新评估。数据分析重点关注与治疗相关的脑激活变化以及稳定的、与治疗无关的组间差异。
根据自我评分,两组的情绪诱发均成功,且未显示出时间依赖性变化。患者在情感加工的核心脑区,如前扣带回皮质、眶额和颞叶区域以及海马体,表现出稳定的激活不足。与治疗相关的中央前回、中央后回、颞下回和额叶区域的信号增加仅限于悲伤情绪。
在关键参与情绪加工的皮质-边缘区域发现了不受治疗和症状改善影响的稳定功能障碍。它们可能反映了患者在情绪调节和情绪记忆过程中的困难。然而,也观察到了与治疗相关的激活变化,证明了抗精神病治疗对改善情绪功能的有效性。它们可能代表了自传体情绪记忆的更多使用以及通过模仿他人情绪来体验情绪的改进策略。